Oligopin: Clinical Trials

6 trials of Oligopin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 1 unknown. 4 Not applicable, 1 Phase 1, 1 Phase 2, 1 Phase 3.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 3, Unknown 1
Phase 11Completed 1
Phase 21Completed 1
Phase 31Completed 1

Follow Oligopin: new trials by email Literature Review of Oligopin trials Research Report on Oligopin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Study to Determine the Safety and Efficacy of Oligopin® on Metabolic Risk Factors in Subjects With Metabolic Syndrome
Oligopin®, Placebo - Metabolic Syndrome
Not applicableUnknownLes Derives Resiniques et Terpeniques402020-06-242021-08-26
Effect of Oligopin® on Skin Ageing
Oligopin, Placebo - Skin Aging
Not applicableCompletedTechnological Centre of Nutrition and Health, Spain742019-11-192022-03-02
Evaluation the Effects of French Maritime Pine Bark Extract on the Clinical Status in Traumatic Brain Injury Patients
Dietary Supplement (OLIGOPIN), Placebo - Traumatic Brain Injury
Phase 1 / Phase 2CompletedMashhad University of Medical Sciences672019-04-142020-05-21
Oligopin Supplementation and Bone Turnover Markers and Antioxidant Changes in Postmenopausal Osteopenic Women
Oligopin, Placebo - Osteopenia
Phase 3CompletedTehran University of Medical Sciences432018-02-012020-05-20
Therapeutic Effects of Pine Bark Extracts in Attention Deficit Hyperactivity Disorder
Oligopin®, Placebo - ADHD
Not applicableCompletedTaipei Medical University322017-10-282019-09-18
Effect of Oligopin® on Blood Pressure.
Placebo, Oligopin® - Blood Pressure, Hypertension
Not applicableCompletedTechnological Centre of Nutrition and Health, Spain242014-02-012022-02-28

Conditions studied

Attention Deficit Disorder with Hyperactivity (1)  ·  Bone Diseases, Metabolic (1)  ·  Brain Injuries, Traumatic (1)  ·  Hypertension (1)  ·  Metabolic Syndrome (1)

Sponsors

Technological Centre of Nutrition and Health, Spain (2)  ·  Les Derives Resiniques et Terpeniques (1)  ·  Mashhad University of Medical Sciences (1)  ·  Taipei Medical University (1)  ·  Tehran University of Medical Sciences (1)

Countries

Iran (2)  ·  Spain (2)  ·  Canada (1)  ·  Taiwan (1)

Top investigators

David Crowley, MD (1)

Results publications

PMID 27765365, PMID 32046747